Your browser doesn't support javascript.
loading
PALB2 mutations and prostate cancer risk and survival.
Wokolorczyk, Dominika; Kluzniak, Wojciech; Stempa, Klaudia; Rusak, Bogna; Huzarski, Tomasz; Gronwald, Jacek; Gliniewicz, Katarzyna; Kashyap, Aniruddh; Morawska, Sylwia; Debniak, Tadeusz; Jakubowska, Anna; Szwiec, Marek; Domagala, Pawel; Lubinski, Jan; Narod, Steven A; Akbari, Mohammad R; Cybulski, Cezary.
Afiliación
  • Wokolorczyk D; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Kluzniak W; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Stempa K; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Rusak B; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Huzarski T; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Gronwald J; Department of Clinical Genetics and Pathology, University of Zielona Góra, Zielona Góra, Poland.
  • Gliniewicz K; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Kashyap A; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Morawska S; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Debniak T; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Jakubowska A; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Szwiec M; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Domagala P; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
  • Lubinski J; Clinics of Oncology, University Hospital in Zielona Góra, Zielona Góra, Poland.
  • Narod SA; Department of Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Akbari MR; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Cybulski C; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Canada.
Br J Cancer ; 125(4): 569-575, 2021 08.
Article en En | MEDLINE | ID: mdl-34006922
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Análisis de Secuencia de ADN / Proteína del Grupo de Complementación N de la Anemia de Fanconi / Mutación Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Br J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Polonia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Análisis de Secuencia de ADN / Proteína del Grupo de Complementación N de la Anemia de Fanconi / Mutación Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Br J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Polonia